Marcel P. Trefny
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Cytotoxic CD39+ tumor-associated NK cells respond to NKG2A blockade in lung cancer.
Journal: Science immunology
Published: June 05, 2026
Serial Killing Assay Using Longitudinal Impedance-Based Tumor Cell Viability Measurement - A Useful Method to Assess T Cell Performance.
Journal: Journal of visualized experiments : JoVE
Published: January 19, 2026
Development of CAR NK Cell Lines Selectively Targeting Cancer Cells Expressing Membrane Hsp70.
Journal: MedComm
Published: June 30, 2025
Metabolites as agents and targets for cancer immunotherapy.
Journal: Nature reviews. Drug discovery
Published: May 15, 2025
Inhibition of Cbl-b restores effector functions of human intratumoral NK cells.
Journal: Journal for immunotherapy of cancer
Published: October 24, 2024
CAR T cells for solid tumors - developments to watch in 2023.
Journal: Expert opinion on biological therapy
Published: March 25, 2024
Ablation of prostaglandin E2 signalling through dual receptor knockout in CAR T cells enhances therapeutic efficacy in solid tumours.
Journal: Nature biomedical engineering
Published: March 19, 2024
Unraveling T-cell Exhaustion: Genetic Screening Meets In Vitro Modeling.
Journal: Cancer research
Published: October 13, 2023
Beyond CAR T cells: exploring alternative cell sources for CAR-like cellular therapies.
Journal: Biological chemistry
Published: October 03, 2023
Dual TLR9 and PD-L1 targeting unleashes dendritic cells to induce durable antitumor immunity.
Journal: Journal for immunotherapy of cancer
Published: April 16, 2023
Last Updated: 09/26/2026